Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Foghorn Therapeutics Inc. | Chief Financial Officer | Stock Option (Right to buy) | 275K | $1.66M | $6.03 | Apr 16, 2024 | Direct |
Sensei Biotherapeutics, Inc. | Director | Common Stock | 8.93K | $7.59K | $0.85 | Jul 10, 2023 | Direct |
Viridian Therapeutics, Inc.\DE | CFO and CBO | Stock Option (Right to Buy) | 108K | Feb 8, 2023 | Direct | ||
Sensei Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 19K | Jun 11, 2024 | Direct |